Altheus Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2012-04-27
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Altheus Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT01586533
- Locations
- 🇺🇸
The Atlanta Center for Gastroenterology, Decatur, Georgia, United States
🇺🇸NCH Medical Group, Arlington Heights, Illinois, United States
🇺🇸Asheville Gastroenterology Associates, P.A., Asheville, North Carolina, United States
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
- First Posted Date
- 2009-11-24
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- Altheus Therapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT01020708
- Locations
- 🇺🇸
Oklahoma Foundation for Digestive Research, Oklahoma City, Oklahoma, United States
© Copyright 2024. All Rights Reserved by MedPath